These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 8054438)
1. Fungemia and colonization with nystatin-resistant Candida rugosa in a burn unit. Dubé MP; Heseltine PN; Rinaldi MG; Evans S; Zawacki B Clin Infect Dis; 1994 Jan; 18(1):77-82. PubMed ID: 8054438 [TBL] [Abstract][Full Text] [Related]
2. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.]. Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489 [TBL] [Abstract][Full Text] [Related]
3. A comparison of susceptibility to five antifungal agents of yeast cultures from burn patients. Still JM; Law EJ; Belcher KE; Spencer SA Burns; 1995 May; 21(3):167-70. PubMed ID: 7794495 [TBL] [Abstract][Full Text] [Related]
4. [Investigation of quantitative and species composition and antifungal drug susceptibility of yeasts isolated from patients with generalized periodontitis complicated by candidosis]. Kutsyk RV; Pavliuk TD Mikrobiol Z; 2003; 65(5):26-9. PubMed ID: 14723159 [TBL] [Abstract][Full Text] [Related]
5. [In vitro susceptibility to antifungal agents of Candida strains isolated from patients with various diseases of the respiratory tract]. Batura-Gabryel H; Wieczorek U; Mlynarczyk W Pneumonol Alergol Pol; 1997; 65(5-6):355-9. PubMed ID: 9340063 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of virulence factors and antifungal susceptibility patterns of different Candida species isolated from the female camel (Camelus dromedarius) genital tract. Sharifzadeh A; Soltani M; Shokri H Mycoses; 2015 Aug; 58(8):478-84. PubMed ID: 26152466 [TBL] [Abstract][Full Text] [Related]
7. In vitro susceptibility of Candida dubliniensis to current and new antifungal agents. Quindós G; Carrillo-Muñoz AJ; Arévalo MP; Salgado J; Alonso-Vargas R; Rodrigo JM; Ruesga MT; Valverde A; Pemán J; Cantón E; Martín-Mazuelos E; Pontón J Chemotherapy; 2000; 46(6):395-401. PubMed ID: 11053905 [TBL] [Abstract][Full Text] [Related]
8. Epidemiology of candidemia in a Turkish tertiary care hospital. Bakir M; Cerikcioglu N; Barton R; Yagci A APMIS; 2006 Sep; 114(9):601-10. PubMed ID: 16948812 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of antifungal susceptibility testing in Candida isolates by Candifast and disk-diffusion method. Giri S; Kindo AJ Indian J Pathol Microbiol; 2014; 57(4):595-7. PubMed ID: 25308014 [TBL] [Abstract][Full Text] [Related]
10. In vitro susceptibilities of rare Candida bloodstream isolates to ravuconazole and three comparative antifungal agents. Pfaller MA; Diekema DJ; Messer SA; Boyken L; Hollis RJ; Jones RN Diagn Microbiol Infect Dis; 2004 Feb; 48(2):101-5. PubMed ID: 14972378 [TBL] [Abstract][Full Text] [Related]
11. In vitro susceptibility of 119 yeast isolates to fluconazole, 5-fluorocytosine, amphotericin B and ketoconazole. Morace G; Manzara S; Dettori G Chemotherapy; 1991; 37(1):23-31. PubMed ID: 2013239 [TBL] [Abstract][Full Text] [Related]
12. In vitro susceptibility of 245 yeast isolates to amphotericin B, 5-fluorocytosine, ketoconazole, fluconazole and itraconazole. Martín E; Parras P; Lozano MC Chemotherapy; 1992; 38(5):335-9. PubMed ID: 1337508 [TBL] [Abstract][Full Text] [Related]
13. Species and susceptibility distribution of 1062 clinical yeast isolates to azoles, echinocandins, flucytosine and amphotericin B from a multi-centre study. Schmalreck AF; Willinger B; Haase G; Blum G; Lass-Flörl C; Fegeler W; Becker K; Mycoses; 2012 May; 55(3):e124-37. PubMed ID: 22233267 [TBL] [Abstract][Full Text] [Related]
14. Antifungal susceptibility and distribution of Candida spp. isolates from the University Hospital in the municipality of Dourados, State of Mato Grosso do Sul, Brazil. Almeida AA; Mesquita CS; Svidzinski TI; Oliveira KM Rev Soc Bras Med Trop; 2013; 46(3):335-9. PubMed ID: 23856873 [TBL] [Abstract][Full Text] [Related]
15. Susceptibilities of Candida species to amphotericin B and fluconazole: the emergence of fluconazole resistance in Candida tropicalis. Yang YL; Ho YA; Cheng HH; Ho M; Lo HJ Infect Control Hosp Epidemiol; 2004 Jan; 25(1):60-4. PubMed ID: 14756222 [TBL] [Abstract][Full Text] [Related]
16. In vitro susceptibility of Candida albicans clinical isolates to eight antifungal agents in Ouagadougou (Burkina Faso). Zida A; Yacouba A; Bamba S; Sangare I; Sawadogo M; Guiguemde T; Kone S; Traore LK; Ouedraogo-Traore R; Guiguemde RT J Mycol Med; 2017 Dec; 27(4):469-475. PubMed ID: 28754462 [TBL] [Abstract][Full Text] [Related]
17. Susceptibilities to amphotericin B and fluconazole of Candida species in Taiwan Surveillance of Antimicrobial Resistance of Yeasts 2006. Yang YL; Wang AH; Wang CW; Cheng WT; Li SY; Lo HJ; Diagn Microbiol Infect Dis; 2008 Jun; 61(2):175-80. PubMed ID: 18304773 [TBL] [Abstract][Full Text] [Related]
18. [Neonatal Candida infections and the antifungal susceptibilities of the related Candida species]. Altuncu E; Bilgen H; Cerikçioğlu N; Ilki A; Ulger N; Bakır M; Akman I; Ozek E Mikrobiyol Bul; 2010 Oct; 44(4):593-603. PubMed ID: 21063972 [TBL] [Abstract][Full Text] [Related]
19. [Antifungal susceptibility of Candida spp. isolates from blood cultures in a five-year period (1997-2001)]. Durán MT; Velasco D; Canle D; Moure R; Villanueva R Enferm Infecc Microbiol Clin; 2003 Nov; 21(9):488-92. PubMed ID: 14572381 [TBL] [Abstract][Full Text] [Related]
20. Emergence of nosocomial candidemia at a teaching hospital in Taiwan from 1981 to 2000: increased susceptibility of Candida species to fluconazole. Hsueh PR; Teng LJ; Yang PC; Ho SW; Luh KT Microb Drug Resist; 2002; 8(4):311-9. PubMed ID: 12523628 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]